title: The use of everolimus to reverse tamoxifen resistance in men with metastatic breast cancer: a case report.
authors.affiliation: Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University, Achrafieh, Beirut, Lebanon.
authors.forename: Joseph
authors.initials: J
authors.lastname: Kattan
authors.forename: Hampig Raphael
authors.initials: HR
authors.lastname: Kourie
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018567:Breast Neoplasms, Male / Q000188:drug therapy*; D044584:Carcinoma, Ductal / Q000188:drug therapy*; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D004965:Estrogen Antagonists / Q000008:administration & dosage; D000068338:Everolimus; D006801:Humans; D008297:Male; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives; D013629:Tamoxifen / Q000008:administration & dosage
chemical_list: D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D013629:Tamoxifen; D000068338:Everolimus; D020123:Sirolimus